YLL545
YLL545 is a potent and selective VEGFR2 inhibitor that blocks VEGF-induced receptor phosphorylation and downstream signaling (pSTAT3, pERK1/2) in HUVECs. It effectively suppresses endothelial cell proliferation, migration, and tube formation in vitro and demonstrates anti-tumor efficacy by inhibiting angiogenesis and inducing apoptosis in breast cancer mouse models.
Product Specifications
CAS Number
1423126-69-5
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction, Stem Cell & Developmental Biology
Smiles
O=C (NC1=CC=C (OC2=NC=NC=3NN=CC23) C=C1) NC4=CC=CC (=C4) C (F) (F) F
Molecular Formula
C19H13F3N6O2
Molecular Weight
414.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6333299-01 0.2 mL
PHF16, CT (PHF16, JADE3, KIAA0215, Protein Jade-3, PHD finger protein 16) (AP)
Sign In for Pricing
View Details 
MBS6333299-02 5x 0.2 mL
PHF16, CT (PHF16, JADE3, KIAA0215, Protein Jade-3, PHD finger protein 16) (AP)
Sign In for Pricing
View Details K6819808 1.0 µg DNA
Htr2b sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details NBP2-54539AF647 100 µL
Mouse Monoclonal PAX8 Antibody (PAX8/1492) [Alexa Fluor 647]
Sign In for Pricing
View Details 
abx320353-01 20 µL
NKG2-A/NKG2-B Type II Integral Membrane Protein (KLRC1) Antibody
Sign In for Pricing
View Details abx320353-02 50 µL
NKG2-A/NKG2-B Type II Integral Membrane Protein (KLRC1) Antibody
Sign In for Pricing
View Details